Clinical Trials
7 trialsNCT05959564 2024-10-21
A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
University of Maryland, College Park
Phase NA Completed
NCT03439085 2024-07-09
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT03856437 2024-03-15
A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
University of Maryland, College Park
Phase NA Completed
NCT03427411 2023-03-28
M7824 in Subjects With HPV Associated Malignancies
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01585428 2018-03-07
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02280811 2017-09-06
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00538850 2014-03-05
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Phase 3 Completed